Achieve Life Sciences is a more derisked case now, thanks to successful financing, progress on shifting its supply chain and ...
In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...
AUSTIN, TX / ACCESS Newswire / July 7, 2026 / AM Technical Solutions (AM), a global architecture, engineering, construction, and commissioning firm specializing in high-technology markets, announces ...
Life sciences executives are entering the second half of 2026 with a split view of their industry: deep unease about the ...
The collaboration pairs Discovery’s global clinical laboratory network and industry leading biorepository with the Idylla™ Platform, a fully automated, sample-to-result, real- ...
4hon MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences ...
Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
By Kunal Das June 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results